Contact this trialFirst, we need to learn more about you.
mTOR inhibitor
Sapanisertib for Bladder Cancer
Recruiting1 awardPhase 2
Ann Arbor, Michigan
This trial studies how well sapanisertib works in treating patients with advanced or metastatic bladder cancer that have specific genetic mutations. Sapanisertib is taken by mouth and aims to stop cancer cell growth by blocking necessary enzymes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service